A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].

  title={A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-$\alpha$-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].},
  author={Takako Yoshino Furukawa and Qinghua Yuan and Zhao-Hui Jin and Winn Aung and Yukie Yoshii and Sumitaka Hasegawa and Hiroko Endo and Masahiro Inoue and Ming-Rong Zhang and Yasuhisa Fujibayashi and Tsuneo Saga},
  journal={Oncology reports},
  volume={34 3},
Positron emission tomography (PET) imaging of tumor hypoxia provides valuable information for cancer treatment planning. Two types of PET tracers, nitroimidazole compounds and [62,64Cu] copper-diacetyl-bis[N(4)-methylthio- semicarbazone] (Cu-ATSM), have been used for imaging hypoxic tumors. High accumulation of these tracers in tumors was shown to predict poor prognosis. Both similar and different intratumoral distributions of these PET tracers have been reported with some studies questioning… 

Figures and Tables from this paper

Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model

The combination of 64Cu-RaftRGD and 64 Cu-ATSM achieved an improved antitumor effect owing to the more uniform intratumoral distribution of radioactivity.

Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma

62Cu-ATSM PET/CT is a more promising imaging method to predict prognosis of patients with glioma compared to 18F-FDG PET/ECT, according to univariate and multivariate analysis.

In Vivo Simultaneous Imaging of Vascular Pool and Hypoxia with a HT-29 Tumor Model: the Application of Dual-Isotope SPECT/PET/CT

A method to simultaneously visualize vascularity and hypoxia within HT-29tumors using in vivo dual-isotope SPECT/PET/CT imaging is developed, indicating the feasibility for in vivo experiments.

Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.

Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research

The aim of this overview is to shed light on selected 3D models and their advantages and disadvantages, especially from the radiopharmacist’s point of view with focus on the suitability of3D models for the radiophilearmacological characterization of novel radiotracers and radiotherapeutics.

JournalOfBasicAndApplied-------------------------------------------------------------------------------------------------------- -

Kashiwa, Japan Institute for Genetic Medicine, Hokkaido University, Kita-15 Nishi-7 Kita-Ku, 060-0815, Sapporo, Japan Department of Nuclear Medicine, Kawasaki Medical School,577 Matsushima, 701-0192,

Positron emission tomography imaging in primary brain tumors

PET/MR imaging of hypoxic atherosclerotic plaque using 64Cu-ATSM



Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer

The results of this study confirm the cell-dependent distribution and retention kinetics of 64Cu-ATSM and underline the need for proper validation of animal models and PET acquisition protocols before exploration of any new clinical applications.

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

  • D. RischinR. Hicks L. Peters
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
PURPOSE To determine the association between tumor hypoxia, treatment regimen, and locoregional failure (LRF) in patients with stage III or IV squamous cell carcinoma of the head and neck randomly

Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)

This study confirmed that pretreatment tumor hypoxia demonstrated by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone) (60Cu-ATSM) is a biomarker of poor prognosis in patients with cervical cancer.

A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers

The fluorinated nitroimidazoles showed similar tumor distributions when compared with immunohistochemistry markers of hypoxia, suggesting variations in tumor standardized uptake value and normal tissue distribution may determine the most appropriate clinical setting for each tracer.

pO2 Polarography Versus Positron Emission Tomography ([18F] Fluoromisonidazole, [18F]-2-Fluoro-2’-Deoxyglucose)

Summarizing the FMISO uptake represents a global value for macroscopic tumor parts and seems highly feasible to evaluate the state of oxygenation in subjacent tumors.

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

Cu-ATSM exhibits selectivity for hypoxic tumor tissue both in vivo and in vitro and may provide a successful diagnostic modality for the detection of tumor ischemia.

In Vivo Visualization of Heterogeneous Intratumoral Distribution of Hypoxia-Inducible Factor-1α Activity by the Fusion of High-Resolution SPECT and Morphological Imaging Tests

High-resolution SPECT images successfully demonstrated heterogeneous intratumoral distribution of 125I-IPOS, a 125I labeled chimeric protein probe that would visualize HIF activity in tumor tissues in vivo.